Toronto, Ontario - TheNewswire - October 3, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased...
Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration PR Newswire MADISON, Wis., Oct. 3, 2023 MADISON, Wis.,...
CAMBRIDGE, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that,...
Sun Life Completes Previously Announced Acquisition of Dialogue Canada NewsWire MONTREAL, Oct. 3, 2023 MONTREAL, Oct. 3, 2023 /CNW/ - Dialogue Health Technologies Inc. (TSX: CARE) ("Dialogue"...
Calgary, Alberta--(Newsfile Corp. - October 3, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it closed its private...
The randomized pivotal Phase 3 study is expected to enroll a total of 354 patients in either Bria-IMT™ combination or physician’s choice therapy (1:1)Positive...
Program Designed to Identify Age-Related Brain Health Issues at an Early Stage, Allowing Effective Provision of Coordinated CareVancouver, British Columbia--(Newsfile...
74 patients enrolledNew sites to further accelerate patient enrollmentOn track to onboard seven new trial sites around the end of November 2023 TORONTO,...
Media Release SYDNEY, AUSTRALIA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”),...
MDNA223 is a bifunctional Superkine designed to activate cancer-killing immune cells via the IL-2 receptor while simultaneously preventing their exhaustion...
WELL Health Completes Clinic Acquisition and Investment Transactions with HEALWELL AI Inc. (formerly MCI Onehealth), and Forms Strategic Alliance Focused on Developing AI Enabled Disease Detection...